Curocell (XKRX:372320) Receivables Turnover : 0.00 (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Curocell Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Curocell's Revenue for the six months ended in Jun. 2024 was ₩0.00 Mil. Curocell's average Accounts Receivable for the six months ended in Jun. 2024 was ₩0.00 Mil.

Curocell Receivables Turnover Historical Data

The historical data trend for Curocell's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Receivables Turnover Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23	Jun24
Receivables Turnover	-	-	-	-	-

Competitive Comparison of Curocell's Receivables Turnover

For the Biotechnology subindustry, Curocell's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Curocell's Receivables Turnover falls into.

Curocell Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Curocell's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Curocell's Receivables Turnover for the quarter that ended in Jun. 2024 is calculated as

	Receivables Turnover (Q: Jun. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Jun. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Curocell (XKRX:372320) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Curocell Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Curocell's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell Headlines

No Headlines